| ORIGINAL ARTICLE |
|
| Year : 2021 | Volume
: 8
| Issue : 1 | Page : 12 |
|
|
Patients with chronic kidney disease have higher acute kidney injury morbidity than those without after SARS-CoV-2 infection
Yuting Song1, Dongdong Mao2, Rong Zou2, Yanglin Hu2, Dan Luo3, Hong Liu2, Can Tu2, Fei Xiong1
1 The First Clinical College of Hubei University of Traditional Chinese Medicine; Department of Nephrology, Wuhan No. 1 Hospital, Wuhan, Hubei Province, China
2 Department of Nephrology, Wuhan No. 1 Hospital, Wuhan, Hubei Province, China
3 Department of Respiratory, Wuhan No. 1 Hospital, Wuhan, Hubei Province, China
Correspondence Address:
Dr. Fei Xiong
The First Clinical College of Hubei University of Traditional Chinese Medicine, No.16, Huangjiahu West Road, Hongshan District, Wuhan 430065, Hubei Province; Department of Nephrology, Wuhan No. 1 Hospital (Wuhan Integrated TCM & Western Medicine Hospital), No.215 Zhongshan Avenue, Wuhan 430022, Hubei Province
China
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/imna.imna_24_21
|
|
|
Background and Objectives: Chronic kidney disease (CKD) and acute kidney injury (AKI) increase the risk of serious disease and mortality in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-infected patients. This study evaluated the occurrence and outcome of AKI in CKD and non-CKD patients infected with SARS-CoV-2. Subjects and Methods: We retrospectively analyzed the medical records of 845 patients with SARS-CoV-2 infection regarding the occurrence and outcome of AKI in a coronavirus disease-2019 (COVID-19)-designated hospital in Wuhan, China, from December 31, 2019, to March 20, 2020. Results: Of the 845 COVID-19 patients, 91 had CKD and 754 had no CKD (non-CKD), of whom 22 and 14 developed AKI, respectively. Finally, 36 patients were included in the analysis. Older patients and those with cardiovascular or cerebrovascular diseases were more likely to develop AKI. More CKD patients progressed to critical illness (72.73%) than non-CKD patients (57.14%), but the degree of AKI in CKD patients was lesser than that in non-CKD patients. Higher urea nitrogen, creatinine, and proteinuria levels were observed in CKD patients. More non-CKD patients were treated with human albumin than CKD patients. The survival probability of CKD patients was lower than that of non-CKD patients, but it was not statistically significant. Conclusion: There were significant differences in the incidence rate of AKI after SARS-CoV-2 infection between CKD and non-CKD patients, and the clinical manifestations and treatments of AKI also differed. These results highlight the necessity of variable treatment methods for optimal clinical management.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
